Logo image of GLT

GLATFELTER CORP (GLT) Stock Fundamental Analysis

NYSE:GLT - New York Stock Exchange, Inc. - US3773201062 - Common Stock - Currency: USD

21.05  -1.57 (-6.94%)

After market: 21.05 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GLT. GLT was compared to 9 industry peers in the Paper & Forest Products industry. Both the profitability and financial health of GLT have multiple concerns. GLT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year GLT has reported negative net income.
In the past year GLT had a positive cash flow from operations.
In multiple years GLT reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: GLT reported negative operating cash flow in multiple years.
GLT Yearly Net Income VS EBIT VS OCF VS FCFGLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.37%, GLT is in line with its industry, outperforming 44.44% of the companies in the same industry.
The Return On Equity of GLT (-32.19%) is worse than 66.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.87%, GLT is in line with its industry, outperforming 55.56% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for GLT is significantly below the industry average of 7.39%.
Industry RankSector Rank
ROA -4.37%
ROE -32.19%
ROIC 0.87%
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%
GLT Yearly ROA, ROE, ROICGLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

With a Operating Margin value of 1.07%, GLT perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
In the last couple of years the Operating Margin of GLT has declined.
GLT has a Gross Margin (10.51%) which is comparable to the rest of the industry.
GLT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.07%
PM (TTM) N/A
GM 10.51%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%
GLT Yearly Profit, Operating, Gross MarginsGLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GLT is destroying value.
GLT has more shares outstanding than it did 1 year ago.
GLT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, GLT has a worse debt to assets ratio.
GLT Yearly Shares OutstandingGLT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
GLT Yearly Total Debt VS Total AssetsGLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 1.82 indicates that GLT is not a great score, but indicates only limited risk for bankruptcy at the moment.
GLT's Altman-Z score of 1.82 is fine compared to the rest of the industry. GLT outperforms 66.67% of its industry peers.
GLT has a Debt/Equity ratio of 4.29. This is a high value indicating a heavy dependency on external financing.
GLT's Debt to Equity ratio of 4.29 is on the low side compared to the rest of the industry. GLT is outperformed by 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.29
Debt/FCF N/A
Altman-Z 1.82
ROIC/WACC0.11
WACC7.95%
GLT Yearly LT Debt VS Equity VS FCFGLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

GLT has a Current Ratio of 2.23. This indicates that GLT is financially healthy and has no problem in meeting its short term obligations.
GLT has a Current ratio of 2.23. This is in the better half of the industry: GLT outperforms 66.67% of its industry peers.
A Quick Ratio of 1.04 indicates that GLT should not have too much problems paying its short term obligations.
GLT has a Quick ratio of 1.04. This is in the lower half of the industry: GLT underperforms 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.04
GLT Yearly Current Assets VS Current LiabilitesGLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

1

3. Growth

3.1 Past

GLT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.18%.
Looking at the last year, GLT shows a decrease in Revenue. The Revenue has decreased by -9.02% in the last year.
Measured over the past years, GLT shows a quite strong growth in Revenue. The Revenue has been growing by 9.85% on average per year.
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.26%
Revenue 1Y (TTM)-9.02%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%0.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GLT Yearly Revenue VS EstimatesGLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
GLT Yearly EPS VS EstimatesGLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 4 6 8 10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GLT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GLT Price Earnings VS Forward Price EarningsGLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

GLT's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. GLT is more expensive than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.55
GLT Per share dataGLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GLATFELTER CORP

NYSE:GLT (11/4/2024, 8:12:13 PM)

After market: 21.05 0 (0%)

21.05

-1.57 (-6.94%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)10-29 2024-10-29/bmo
Earnings (Next)N/A N/A
Inst Owners80.31%
Inst Owner Change-70.08%
Ins Owners6.55%
Ins Owner Change0%
Market Cap743.91M
Analysts80
Price Target9.18 (-56.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.57
P/FCF N/A
P/OCF 102.13
P/B 3.6
P/tB N/A
EV/EBITDA 20.55
EPS(TTM)-0.85
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)0.21
OCFY0.98%
SpS37.05
BVpS5.85
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.37%
ROE -32.19%
ROCE 1.11%
ROIC 0.87%
ROICexc 0.9%
ROICexgc 1.09%
OM 1.07%
PM (TTM) N/A
GM 10.51%
FCFM N/A
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%
ROICexc(3y)1.4%
ROICexc(5y)2.53%
ROICexgc(3y)1.77%
ROICexgc(5y)3.33%
ROCE(3y)1.65%
ROCE(5y)2.9%
ROICexcg growth 3Y-33.98%
ROICexcg growth 5Y-5.57%
ROICexc growth 3Y-31.54%
ROICexc growth 5Y-3.54%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%
F-Score4
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 4.29
Debt/FCF N/A
Debt/EBITDA 11.53
Cap/Depr 48.06%
Cap/Sales 2.31%
Interest Coverage 0.21
Cash Conversion 9.46%
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 1.04
Altman-Z 1.82
F-Score4
WACC7.95%
ROIC/WACC0.11
Cap/Depr(3y)52.93%
Cap/Depr(5y)52.63%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.26%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.02%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%0.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-37.96%
EBIT growth 3Y-25.3%
EBIT growth 5Y1.43%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y122.55%
OCF growth 3YN/A
OCF growth 5YN/A